Theglobeandmail

Published October 20, 2026 · Updated October 21, 2026

Optimi Health Corp (OPTH-Q) Stock Price and News - The Globe and Mail

Read the full story at Theglobeandmail

Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia. October 20, 2026.